NCT00752115View on ClinicalTrials.gov

Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

December 31, 2010

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

sildenafil

50mg, day1,8 and 15 in each cycle

DRUG

placebo

1 tab, day 1,8 and 15 in each cycle.

DRUG

paclitaxel (taxol)

paclitaxel; 70mg/m2 div on day 1, 8 and 15, every 28 days

DRUG

carboplatin (palaplatin)

carboplatin; AUC=6 on day 1, every 28 days

Trial Locations (1)

Unknown

Hamamatsu University School of Medicine, Hamamatsu

All Listed Sponsors
lead

Hamamatsu University

OTHER

NCT00752115 - Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter